DSC3 and colorectal carcinoma: To confirm the MSP results and further evaluate the methylation status of DSC3 in CRC cell lines, BS was performed for 21 CpG sites (−275, −272, −269, -260, −250, −224, −219, −215, −210, −204, −201, −199, −190, −183, −160, −150, −142, −138, −136, −132, and −128) of the promoter region.